Moonshot

The Safavi Impact Institute Sponsors NASA's Space Center Houston's pilot education program in Austria

Retrieved on: 
Vendredi, juin 14, 2024
Student, Research, NASA, Curriculum, Moonshot, History, Tourism

VIENNA, June 14, 2024 /PRNewswire/ -- The Safavi Impact Institute in Austria has signed a cooperation agreement with the Federal Ministry of Education, Science and Research and representatives of the US space agency NASA's Space Center Houston to sponsor an education programme.  

Key Points: 
  • The Safavi Impact Institute signs a cooperative agreement with Martin Polaschek, Austria's Federal Minister of Education, Science and Research and with Mr. William Harris, CEO of NASA's Space Center Houston
    The Moonshot programme will be delivered by Novi Education, Space Center Houston's globally aligned education provider
    VIENNA, June 14, 2024 /PRNewswire/ -- The Safavi Impact Institute in Austria has signed a cooperation agreement with the Federal Ministry of Education, Science and Research and representatives of the US space agency NASA's Space Center Houston to sponsor an education programme.
  • As announced by Federal Minister Mr. Martin Polaschek, The Safavi Impact Institute will sponsor for the first time the Austria pilot programme of Space Center Houston's Moonshot education curriculum.
  • Mr. Harris stated "We are honored to be a partner of Austria, Novi Education and The Safavi Impact Institute".
  • Mr. Safavi further added "We are honored for The Safavi Impact Institute to bring to Austria such a milestone project and to also sponsor the pilot programme."

The Safavi Impact Institute Sponsors NASA's Space Center Houston's pilot education program in Austria

Retrieved on: 
Vendredi, juin 14, 2024
Student, Research, NASA, Curriculum, Moonshot, History, Tourism

VIENNA, June 14, 2024 /PRNewswire/ -- The Safavi Impact Institute in Austria has signed a cooperation agreement with the Federal Ministry of Education, Science and Research and representatives of the US space agency NASA's Space Center Houston to sponsor an education programme.  

Key Points: 
  • The Safavi Impact Institute signs a cooperative agreement with Martin Polaschek, Austria's Federal Minister of Education, Science and Research and with Mr. William Harris, CEO of NASA's Space Center Houston
    The Moonshot programme will be delivered by Novi Education, Space Center Houston's globally aligned education provider
    VIENNA, June 14, 2024 /PRNewswire/ -- The Safavi Impact Institute in Austria has signed a cooperation agreement with the Federal Ministry of Education, Science and Research and representatives of the US space agency NASA's Space Center Houston to sponsor an education programme.
  • As announced by Federal Minister Mr. Martin Polaschek, The Safavi Impact Institute will sponsor for the first time the Austria pilot programme of Space Center Houston's Moonshot education curriculum.
  • Mr. Harris stated "We are honored to be a partner of Austria, Novi Education and The Safavi Impact Institute".
  • Mr. Safavi further added "We are honored for The Safavi Impact Institute to bring to Austria such a milestone project and to also sponsor the pilot programme."

Inocras and Massive Bio Forge Groundbreaking Alliance to Revolutionize Cancer Care with Whole-Genome Insights and Clinical Trial Matching

Retrieved on: 
Lundi, juin 3, 2024
Biotechnology, Oncology, Health, Artificial Intelligence, Data Management, Technology, Genetics, Clinical Trials, Partner, Biomarker, CLIA, Multimedia, Patient, Ecosystem, Cancer, Medicine, National Cancer Institute, Drug development, Moonshot, Clinical trial, AI, Genetic testing, CAP, M&A, Roger Hawkins (drummer), SBIR, Whole genome sequencing, Partnership, Physician, WGS

Inocras, a leading AI-driven whole genome testing company, and Massive Bio, a cutting-edge AI-driven clinical trial matching platform provider, have joined forces to set a new standard for cancer patient care.

Key Points: 
  • Inocras, a leading AI-driven whole genome testing company, and Massive Bio, a cutting-edge AI-driven clinical trial matching platform provider, have joined forces to set a new standard for cancer patient care.
  • This strategic collaboration leverages Inocras's expertise in whole genome sequencing (WGS) and bioinformatics alongside Massive Bio's advanced AI technology for clinical trial matching, with the shared mission of enhancing personalized care for cancer patients.
  • Given the historically burdensome task of finding suitable clinical trials for cancer patients, partnering with Massive Bio is paramount.
  • Utilizing AI to enhance equitable access and precision targeting for clinical trial matching, drug matching, and drug development, Massive Bio is committed to breaking down barriers in clinical trial enrollment, fostering value-based oncology decisions, and facilitating data-driven cancer treatment.

Sinaptica Therapeutics Selected for StartUp Health’s Alzheimer’s Moonshot

Retrieved on: 
Mercredi, mai 22, 2024
Neurology, Other Health, Health, Pharmaceutical, Clinical Trials, Patient, Gates Ventures, FDA, Therapy, Disease, Moonshot, Default mode network, Alzheimer's disease, Oxford University Press, Medicine, University of Oxford, Pharmaceutical industry

Sinaptica Therapeutics, Inc ., a clinical-stage company leading the development of a new class of personalized neuromodulation therapeutics to treat Alzheimer’s (AD) and other neurodegenerative diseases, today announced that it has been selected to join StartUp Health’s Alzheimer’s Moonshot .

Key Points: 
  • Sinaptica Therapeutics, Inc ., a clinical-stage company leading the development of a new class of personalized neuromodulation therapeutics to treat Alzheimer’s (AD) and other neurodegenerative diseases, today announced that it has been selected to join StartUp Health’s Alzheimer’s Moonshot .
  • “Sinaptica is honored to be included in this hand-selected group of innovators working to end Alzheimer’s – a goal which we believe will require combinatorial approaches,” said Sinaptica CEO Ken Mariash.
  • “Sinaptica brings a bold new personalized neuromodulation approach that can be combined with virtually any drug, given its near-total lack of side effects.
  • “We created the Alzheimer’s Moonshot to bring together trailblazers, support new approaches and rapidly accelerate progress in this challenging disease.

Cancer Moonshot Gets a Booster Shot from This AI-Driven Clinical Research Platform

Retrieved on: 
Lundi, mai 13, 2024
Partnership, CTMS, Patient, Cell, Rest, Radius, IIT, Complex, Hope, CCRP, Tata Memorial Centre, Clinical trial, Developing country, Safety, Pulitzer Prize, Western world, Conference, Cancer Moonshot, Disease, Biography, Emperor, Connect, Data management, Moonshot, AI, Death, Cancer, Research, Gene, EDC, Brain, Leukemia, Associate, BIO, Clinical data management, Society, Electronic data capture, RWD, NIH, Pharmaceutical industry

MANASSAS, Va., May 13, 2024 /PRNewswire-PRWeb/ -- The clinical trial landscape is marred by persistent operational inefficiencies that have only been marginally addressed by the proliferation of technology and the shift to remote trial operations. 2024 is seeing a surge in the fight against cancer, with cancer clinical trials dominating the rest. (1) Dr. Rajasimha notes, "Despite the AI revolution, digital transformation initiatives, and the advent of remote operations, the core goals of clinical trials—to assess the safety and efficacy of treatment options—remain unchanged. They are also getting increasingly inefficient, expensive, longer, and complex due to short-sighted point solutions that address specific parts of the drug development process. We need comprehensive solutions to this nagging problem - a piecemeal approach has resulted in 90% failure rate of candidate drugs in the 'valley of death' and 30% trial terminations due to poor enrollment." (2)

Key Points: 
  • President Biden's loss of his beloved son to brain cancer in 2015 inspired the Cancer Moonshot initiative.
  • 2024 is seeing a surge in the fight against cancer, with cancer clinical trials dominating the rest.
  • His commitment aligns with the audacious goals of the Whitehouse's Cancer Moonshot initiative, forging a powerful partnership towards excellence in Cancer clinical research and treatment.
  • Harnessing cutting-edge technologies like AI, driving breakthroughs in precision cancer treatment options, as validated by recent NIH research.

Massive Bio Unveils Groundbreaking Oncology/Hematology AI Platform at ASCO 2024: Revolutionizing Oncology/Hematology with AI Driven Personalized Insights for Clinical Trial Accessibility

Retrieved on: 
Mardi, mai 7, 2024
Research, General Health, Pharmaceutical, Data Management, Oncology, Technology, Artificial Intelligence, Health Technology, Clinical Trials, Science, Other Technology, Health, Other Science, Roger Hawkins (drummer), HIPAA, Cancer, Ecosystem, GDPR, AI, LATAM, Doctor of Philosophy, National Cancer Institute, ChromeOS, PIPEDA, Patient, M&A, Moonshot, Physician, Multimedia, Drug development, SBIR, Clinical trial, Medical device

View the full release here: https://www.businesswire.com/news/home/20240507335842/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20240507335842/en/
    Selin Kurnaz, PhD, CEO of Massive Bio, states, “At Massive Bio, our mission transcends traditional clinical trial matching.
  • With our AI-driven system, we’re not just facilitating connections; we’re revolutionizing how oncologists/hematologists, patients, and trials interact.
  • “Join us in advancing the future of oncology, where AI empowers more precise, efficient, and patient-centric clinical practices,” encourages Dr. Kurnaz.
  • Founded in 2015 by a team of clinical, technology, and M&A executives, Massive Bio boasts a global presence with nearly 100 people across 12 countries.

Drupal lead Dries Buytaert announces a completely new Drupal CMS 23 years after its creation

Retrieved on: 
Mercredi, mai 8, 2024
Breakthrough Starshot, Web standards, Moonshot, Drupal Association, Wets and dries, Online shopping

PORTLAND, Ore., May 8, 2024 /PRNewswire-PRWeb/ -- Twenty-three years after creating Drupal as a university student and hundreds of thousands of websites later, Dries Buytaert announced today that a new version of Drupal will launch at the end of 2024. Drupal is an Open Source CMS that is foundational to a great digital experience platform. Its reliable, highly secure, and flexible tools build the versatile, structured content needed to create dynamic web experiences.

Key Points: 
  • Drupal Starshot will leverage Drupal Core but have a different governance model to move fast, allowing for more innovation more quickly.
  • On 6 May, founder and project lead Dries Buytaert gave an inspiring keynote—also known as the Driesnote—introducing this completely new version of Drupal: Drupal Starshot.
  • After Drupal Starshot is introduced, when someone visits the Drupal.org download page, both traditional Drupal Core and Drupal Starshot will be available (under a different name, still to be determined).
  • Drupal Core will still be the fundamental building block of Drupal Starshot and can still be used independently from Drupal Starshot for custom builds.

Healing Realty Trust Appoints Three Advisory Board Members Across Strategic Sectors

Retrieved on: 
Mardi, avril 16, 2024
Education, Alnylam Pharmaceuticals, Naval aviation, News, Advisory board, Strategic planning, TGO, Navy, Roche, HRT, Biotechnology, Pfizer, Mental health, Moonshot, Bill, Government, Growth, Fortune 500

Advisory Board members include Darin Gardner, E. Matthew "Whiz" Buckley, and Vitaly "Vic" Pirotsky.

Key Points: 
  • Advisory Board members include Darin Gardner, E. Matthew "Whiz" Buckley, and Vitaly "Vic" Pirotsky.
  • "We are honored to welcome an Advisory Board with invaluable wisdom across strategic sectors aligned with our mission," said Joe Caltabiano, CEO of HRT.
  • "Darin, Vic and Whiz bring decades of experience in areas such as pharmaceuticals, behavioral and mental health, government, psychedelics, veterans affairs, fundraising, and more.
  • Alongside our executive and board members, this collective effort is well-positioned to revolutionize the conventional real estate investment space and address the lack of clinical infrastructure to support the administration of critical healthcare services and novel treatments."

Healthcare Revolution 2024: Largest Industry Event Moves to Drive Superior Results in Healthcare and Medical Tourism

Retrieved on: 
Jeudi, avril 11, 2024
Korea Tourism Organization, Medical tourism, Organizational culture, AI, Health, Partnership, BEACH, PALM, Asan Medical Center, JD, EST, Culture, Medical director, Growth, Moonshot, Pharmaceutical industry

Learn exciting strategies to get ahead in the ever-evolving medical tourism landscape and ways to optimize your corporate health systems that no one else will teach you.

Key Points: 
  • Learn exciting strategies to get ahead in the ever-evolving medical tourism landscape and ways to optimize your corporate health systems that no one else will teach you.
  • This year's event themed "Optimizing Costs, Elevating Programs, and Achieving Superior Results," again focuses on the three key Moonshots launched a few years ago – Costs, Culture, and Care.
  • "HREV 2024 is another exciting time to get insights into new solutions to solve pressing challenges in today's healthcare landscape.
  • Healthcare Revolution 2024 is in partnership with the Medical Tourism Association and is sponsored by the Korea Tourism Organization, South Korea's official corporation in charge of the country's tourism industry.

Healthcare Revolution 2024: Largest Industry Event Moves to Drive Superior Results in Healthcare and Medical Tourism

Retrieved on: 
Jeudi, avril 11, 2024
Korea Tourism Organization, Medical tourism, Organizational culture, AI, Health, Partnership, BEACH, PALM, Asan Medical Center, JD, EST, Culture, Medical director, Growth, Moonshot, Pharmaceutical industry

Learn exciting strategies to get ahead in the ever-evolving medical tourism landscape and ways to optimize your corporate health systems that no one else will teach you.

Key Points: 
  • Learn exciting strategies to get ahead in the ever-evolving medical tourism landscape and ways to optimize your corporate health systems that no one else will teach you.
  • This year's event themed "Optimizing Costs, Elevating Programs, and Achieving Superior Results," again focuses on the three key Moonshots launched a few years ago – Costs, Culture, and Care.
  • "HREV 2024 is another exciting time to get insights into new solutions to solve pressing challenges in today's healthcare landscape.
  • Healthcare Revolution 2024 is in partnership with the Medical Tourism Association and is sponsored by the Korea Tourism Organization, South Korea's official corporation in charge of the country's tourism industry.